FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:201-202 July 15, 1993 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The belief that a depression of cardiac contractility is the fundamental defect in patients with chronic heart failure has led to the development during the past 20 years of nearly 100 new drugs with positive inotropic activity. Although all these agents exert favorable hemodynamic effects, none have produced consistent improvement in symptoms or exercise tolerance, and many have shortened the survival of patients with heart failure^1,2. Questions about efficacy and safety have surfaced regardless of the drug's mechanism of action, but there has been particular concern about agents that act by inhibiting cyclic AMP phosphodiesterase (e.g., milrinone)². Given . . . [Full Text of this Article]

References

Related Letters:

Vesnarinone for Heart Failure
Swedberg K., Wedel H., Neely D., Schwartz A., Feldman A. M., Bristow M. R., Parmley W. W., Packer M.
Extract | Full Text  
N Engl J Med 1994; 330:64-66, Jan 6, 1994. Correspondence

This article has been cited by other articles:

• De Luca, L., Colucci, W. S., Nieminen, M. S., Massie, B. M., Gheorghiade, M. (2006). Evidence-based use of levosimendan in different clinical settings. Eur Heart J 27: 1908-1920 [Abstract] [Full Text]  
• Tokuda, Y., Grant, P. W., Wolfenden, H. D., Manganas, C., Lyon, W. J., Murala, J. S.K. (2006). Levosimendan for patients with impaired left ventricular function undergoing cardiac surgery. ICVTS 5: 322-326 [Abstract] [Full Text]  
• Michaels, A. D., McKeown, B., Kostal, M., Vakharia, K. T., Jordan, M. V., Gerber, I. L., Foster, E., Chatterjee, K. (2005). Effects of Intravenous Levosimendan on Human Coronary Vasomotor Regulation, Left Ventricular Wall Stress, and Myocardial Oxygen Uptake. Circulation 111: 1504-1509 [Abstract] [Full Text]  
• Deswal, A., Petersen, N. J., Feldman, A. M., White, B. G., Mann, D. L. (2001). Effects of Vesnarinone on Peripheral Circulating Levels of Cytokines and Cytokine Receptors in Patients With Heart Failure : A Report From the Vesnarinone Trial. Chest 120: 453-459 [Abstract] [Full Text]  
• Slawsky, M. T., Colucci, W. S., Gottlieb, S. S., Greenberg, B. H., Haeusslein, E., Hare, J., Hutchins, S., Leier, C. V., LeJemtel, T. H., Loh, E., Nicklas, J., Ogilby, D., Singh, B. N., Smith, W. (2000). Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure. Circulation 102: 2222-2227 [Abstract] [Full Text]  
• Tajima, M., Weinberg, E. O., Bartunek, J., Jin, H., Yang, R., Paoni, N. F., Lorell, B. H. (1999). Treatment With Growth Hormone Enhances Contractile Reserve and Intracellular Calcium Transients in Myocytes From Rats With Postinfarction Heart Failure. Circulation 99: 127-134 [Abstract] [Full Text]  
• Stevenson, L. W. (1998). Inotropic Therapy for Heart Failure. NEJM 339: 1848-1850 [Full Text]  
• Lee, J.A, Allen, D.G (1997). Calcium sensitisers: mechanisms of action and potential usefulness as inotropes. Cardiovasc Res 36: 10-20 [Full Text]  
• Torre-Amione, G., Kapadia, S., Lee, J., Durand, J.-B., Bies, R. D., Young, J. B., Mann, D. L. (1996). Tumor Necrosis Factor-{alpha} and Tumor Necrosis Factor Receptors in the Failing Human Heart. Circulation 93: 704-711 [Abstract] [Full Text]  
• Altschuld, R. A., Starling, R. C., Hamlin, R. L., Billman, G. E., Hensley, J., Castillo, L., Fertel, R. H., Hohl, C. M., Robitaille, P.-M. L., Jones, L. R., Xiao, R.-P., Lakatta, E. G. (1995). Response of Failing Canine and Human Heart Cells to ß2-Adrenergic Stimulation. Circulation 92: 1612-1618 [Abstract] [Full Text]  
• Swedberg, K., Wedel, H., Neely, D., Schwartz, A., Feldman, A. M., Bristow, M. R., Parmley, W. W., Packer, M. (1994). Vesnarinone for Heart Failure. NEJM 330: 64-66 [Full Text]